The COPD control panel: towards personalised medicine in COPD

Alvar Agusti, William MacNee

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease whose assessment and management have traditionally been based on the severity of airflow limitation (forced expiratory volume in 1 s (FEV1)). Yet, it is now clear that FEV1 alone cannot describe the complexity of the disease. In fact, the recently released Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011 revision has proposed a new combined assessment method using three variables (symptoms, airflow limitation and exacerbations).
Original languageEnglish
Pages (from-to)687-90
Number of pages4
JournalThorax
Volume68
Issue number7
DOIs
Publication statusPublished - Jul 2013

Keywords

  • Disease Management
  • Forced Expiratory Volume
  • Humans
  • Individualized Medicine
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive
  • Respiratory Function Tests
  • Severity of Illness Index

Fingerprint Dive into the research topics of 'The COPD control panel: towards personalised medicine in COPD'. Together they form a unique fingerprint.

Cite this